219 related articles for article (PubMed ID: 36195187)
21. Recent Progress in Machine Learning-based Prediction of Peptide Activity for Drug Discovery.
Wu Q; Ke H; Li D; Wang Q; Fang J; Zhou J
Curr Top Med Chem; 2019; 19(1):4-16. PubMed ID: 30674262
[TBL] [Abstract][Full Text] [Related]
22. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
Dennison SR; Whittaker M; Harris F; Phoenix DA
Curr Protein Pept Sci; 2006 Dec; 7(6):487-99. PubMed ID: 17168782
[TBL] [Abstract][Full Text] [Related]
23. Pore-forming Peptides: A New Treatment Option for Cancer.
Jahanafrooz Z; Mokhtarzadeh A
Curr Med Chem; 2022; 29(23):4078-4096. PubMed ID: 34825864
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis, and Biological Evaluation of Novel Cholesteryl Peptides with Anticancer and Multidrug Resistance-Reversing Activities.
Deng X; Qiu Q; Wang X; Huang W; Qian H
Chem Biol Drug Des; 2016 Mar; 87(3):374-81. PubMed ID: 26390861
[TBL] [Abstract][Full Text] [Related]
25. Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs.
Lath A; Santal AR; Kaur N; Kumari P; Singh NP
Biotechnol Genet Eng Rev; 2023 Apr; 39(1):45-84. PubMed ID: 35699384
[TBL] [Abstract][Full Text] [Related]
26. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
[TBL] [Abstract][Full Text] [Related]
27. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology.
Tornesello AL; Buonaguro L; Tornesello ML; Buonaguro FM
Molecules; 2017 Aug; 22(8):. PubMed ID: 28767081
[TBL] [Abstract][Full Text] [Related]
28. On the selectivity and efficacy of defense peptides with respect to cancer cells.
Harris F; Dennison SR; Singh J; Phoenix DA
Med Res Rev; 2013 Jan; 33(1):190-234. PubMed ID: 21922503
[TBL] [Abstract][Full Text] [Related]
29. Anticancer Activities of Natural and Synthetic Peptides.
Hilchie AL; Hoskin DW; Power Coombs MR
Adv Exp Med Biol; 2019; 1117():131-147. PubMed ID: 30980357
[TBL] [Abstract][Full Text] [Related]
30. The Potential Use of Peptides in Cancer Treatment.
Yavari B; Mahjub R; Saidijam M; Raigani M; Soleimani M
Curr Protein Pept Sci; 2018; 19(8):759-770. PubMed ID: 29332577
[TBL] [Abstract][Full Text] [Related]
31. Pleiotropic Anticancer Properties of Scorpion Venom Peptides:
Mikaelian AG; Traboulay E; Zhang XM; Yeritsyan E; Pedersen PL; Ko YH; Matalka KZ
Drug Des Devel Ther; 2020; 14():881-893. PubMed ID: 32161447
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides.
Raucher D; Moktan S; Massodi I; Bidwell GL
Expert Opin Drug Deliv; 2009 Oct; 6(10):1049-64. PubMed ID: 19743895
[TBL] [Abstract][Full Text] [Related]
33. From a pro-apoptotic peptide to a lytic peptide: One single residue mutation.
Zhou XR; Zhang Q; Tian XB; Cao YM; Liu ZQ; Fan R; Ding XF; Zhu Z; Chen L; Luo SZ
Biochim Biophys Acta; 2016 Aug; 1858(8):1914-25. PubMed ID: 27207743
[TBL] [Abstract][Full Text] [Related]
34. DRACP: a novel method for identification of anticancer peptides.
Zhao T; Hu Y; Zang T
BMC Bioinformatics; 2020 Dec; 21(Suppl 16):559. PubMed ID: 33323099
[TBL] [Abstract][Full Text] [Related]
35. Survey of In-silico Prediction of Anticancer Peptides.
Ye N
Curr Top Med Chem; 2021; 21(15):1310-1318. PubMed ID: 34126901
[TBL] [Abstract][Full Text] [Related]
36. Efficient Mining of Anticancer Peptides from Gut Metagenome.
Ma Y; Liu X; Zhang X; Yu Y; Li Y; Song M; Wang J
Adv Sci (Weinh); 2023 Sep; 10(25):e2300107. PubMed ID: 37382183
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities.
Zhang B; Shi W; Li J; Liao C; Yang L; Huang W; Qian H
Chem Biol Drug Des; 2017 Nov; 90(5):972-980. PubMed ID: 28524273
[TBL] [Abstract][Full Text] [Related]
38. Peptide motifs for cell-surface intervention: application to anti-infective and biopharmaceutical development.
Monk BC; Harding DR
BioDrugs; 2005; 19(4):261-78. PubMed ID: 16128608
[TBL] [Abstract][Full Text] [Related]
39. Peptide-based cancer therapy: opportunity and challenge.
Wu D; Gao Y; Qi Y; Chen L; Ma Y; Li Y
Cancer Lett; 2014 Aug; 351(1):13-22. PubMed ID: 24836189
[TBL] [Abstract][Full Text] [Related]
40. Bioactive peptides for anticancer therapies.
Zhang Y; Wang C; Zhang W; Li X
Biomater Transl; 2023; 4(1):5-17. PubMed ID: 37206303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
